SCHEMBL3585927

SCHEMBL3585927

c1ccc2c(-n3ncc4cnc(Nc5ccc(N6CCOCC6)cc5)nc43)cccc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT6 P42226 5/20 0.53
PLK4 O00444 2/20 0.53
IGF1R P08069 1/20 0.51
AXL P30530 1/20 0.50
CDK4 P11802 4/20 0.49
CCND3 P30281 3/20 0.49
AURKA O14965 2/20 0.49
CCND1 P24385 2/20 0.49
CCND2 P30279 2/20 0.49
CCNA2 P20248 2/20 0.49
CDK2 P24941 2/20 0.49
CDK6 Q00534 2/20 0.49
CCNK O75909 1/20 0.49
CDK9 P50750 1/20 0.49
SYK P43405 1/20 0.49
AURKB Q96GD4 1/20 0.48
PDGFRB P09619 1/20 0.48
SLC2A1 P11166 1/20 0.48
FGFR1 P11362 1/20 0.48
SRC P12931 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1356073 0.92 STAT6 (0.50) STAT6PLK4IGF1RAXLCDK4
SCHEMBL3571516 0.89 EGFR (0.56) CDK4CCND3AURKACCND1CCND2
SCHEMBL3588808 0.89 CDK4 (0.54) STAT6CDK4CCND3CCND1CCND2
SCHEMBL1355881 0.85 STAT6 (0.57) STAT6PLK4IGF1RCDK4CCND3
SCHEMBL3587747 0.82 CDK4 (0.51) STAT6CDK4CCND3CCND1CCND2
SCHEMBL3583178 0.82 SRC (0.42) CDK4CCND3CCND1CCND2CCNA2
SCHEMBL1356168 0.82 STAT6 (0.57) STAT6PLK4IGF1RAXLCDK4
SCHEMBL1355600 0.80 SYK (0.54) STAT6PLK4IGF1RCDK4CCND3
SCHEMBL3590227 0.80 MAPK10 (0.49) STAT6CDK4CCND3CCND1CCND2
SCHEMBL1355852 0.78 FGFR4 (0.63) STAT6CDK4CCND3AURKACCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190787-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC 2010-07-29 US claimed
US-20100190787-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190787-A1 Modulators of Mitotic Kinases CDK1, BUB1, BUB1B STAT6 2276/4885PLK4 13/4885IGF1R 3119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.